Berberine combined with atorvastatin downregulates LOX-1 expression through the ET-1 receptor in monocyte/macrophages

Unlooked-for Significance of Cardiac Versus Vascular Effects of Endothelin-1 in the Pathophysiology of Pulmonary Arterial Hypertension

(2013) Kumiko Taguchi et al.   CIRCULATION RESEARCH

Oxidized LDL to autoantibodies against oxLDL ratio – The new biomarker associated with carotid atherosclerosis and cardiovascular complications in dialyzed patients

(2012) Krystyna Pawlak et al.   ATHEROSCLEROSIS

Endothelin in hypertension

(2012) Yohann Rautureau et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-κB activation

(2012) Suowen Xu et al.   Translational Research

Oxidative Stress and Lectin-Like Ox-LDL-Receptor LOX-1 in Atherogenesis and Tumorigenesis

(2011) Jingjun Lu et al.   ANTIOXIDANTS & REDOX SIGNALING

Acidity increases the uptake of native LDL by human monocyte-derived macrophages

(2011) Riia Plihtari et al.   ATHEROSCLEROSIS

Oxidized LDL, LOX-1 and Atherosclerosis

(2011) Sona Mitra et al.   CARDIOVASCULAR DRUGS AND THERAPY

Reciprocal coordination of a combination oral contraceptive containing desogestrel+ethinyl estradiol on the expression of LOX-1 and LDLR in placental trophoblast cells

(2011) Hemlata Pandey et al.   CONTRACEPTION

Effects of total glucosides from paeony (Paeonia lactiflora Pall) roots on experimental atherosclerosis in rats

(2011) Jing Li et al.   JOURNAL OF ETHNOPHARMACOLOGY

Toll-like Receptor 4 Mediates Oxidized LDL-Induced Macrophage Differentiation to Foam Cells

(2011) Kenneth W. Howell et al.   JOURNAL OF SURGICAL RESEARCH

Role of endothelin in the cardiovascular system

(2011) Fernando Rodríguez-Pascual et al.   PHARMACOLOGICAL RESEARCH

Effects of Berberine on Expression of LOX-1 and SR-BI in Human Macrophage-Derived Foam Cells Induced by ox-LDL

(2010) Siming Guan et al.   AMERICAN JOURNAL OF CHINESE MEDICINE

From endothelial dysfunction to atherosclerosis

(2010) S. Sitia et al.   AUTOIMMUNITY REVIEWS

Atorvastatin Reduces Plaque Vulnerability in an Atherosclerotic Rabbit Model by Altering the 5-Lipoxygenase Pathway

(2010) Guangyi Zhou et al.   CARDIOLOGY

SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis

(2010) Sokrates Stein et al.   EUROPEAN HEART JOURNAL

EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling

(2010) Hsiu-Chung Ou et al.   JOURNAL OF APPLIED PHYSIOLOGY

Curcumin Reduces Angiotensin II–mediated Cardiomyocyte Growth via LOX-1 Inhibition

(2010) Bum-Yong Kang et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Resveratrol Attenuates Oxidized LDL-Evoked Lox-1 Signaling and Consequently Protects against Apoptotic Insults to Cerebrovascular Endothelial Cells

(2010) Huai-Chia Chang et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Atorvastatin Reduces Macrophage Accumulation in Atherosclerotic Plaques

(2010) Massimo Puato et al.   STROKE

Oxidized LDL: Diversity, Patterns of Recognition, and Pathophysiology

(2009) Irena Levitan et al.   ANTIOXIDANTS & REDOX SIGNALING

The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice

(2009) A. M. D. Watson et al.   DIABETOLOGIA

Lectin-Like Oxidized LDL Receptor-1 (LOX-1) Expression in the Tubulointerstitial Area Likely Plays an Important Role in Human Diabetic Nephropathy

(2009) Naoyuki Yamamoto et al.   INTERNAL MEDICINE

Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet-Induced Obesity and Diabetes in Mice

(2008) P. D. Cani et al.   DIABETES